Chronic Heart Failure
Recent findings in chronic heart failure described by P. Aidelsburger and colleagues
Published in Medical Device Business Week, April 9th, 2008
According to recent research published in the journal Clinical Research in Cardiology, " The aim of the study was to assess the incremental cost-effectiveness ratio (ICER) of Cardiac Resynchronization Therapy in combination with an Implantable Cardioverter Defibrillator (CRT-D) plus Optimal Pharmacological Therapy (OPT) compared to OPT alone in patients with chronic heart failure. Methods and results A decision analytic model was used to estimate the ICER from a German Health Care System perspective."
"Effectiveness data were used as reported in the COMPANION study. Direct medical costs were considered for inpatient and outpatient treatments. Resource utilization...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Allergies
Relief "In Sight" for Allergy Sufferers - Anesthesia
Smiths Medical and MedAssets Supply Chain Systems Sign Multi-Year Supply Agreement - Angiology
Clinical Trial Begins for Innovative Drug-Eluting Stent with Unique Reservoir Technology - Atrial Fibrillation
CryoCath Introduces Arctic Front in Australia - Atrial Fibrillation
New Multi-Electrode Ablation Catheters and RF Generator Featured at American College of Cardiology Scientific Sessions - Biopharmaceuticals
Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
